← Alle mensen

AV

Annemiek van Ommen-Nijhof

2 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Health-related quality of life with first- vs tweedelijns CDK4/6 inhibitor use in gevorderd breast cancer: results fr...
Journal of the National Cancer Institute · 1 maart 2026
Health economic outcomes and costs of CDK4/6 inhibitor use in first- versus tweedelijns for gevorderd breast cancer: ...
European journal of cancer (Oxford, England : 1990) · 9 december 2025